**Figure 9.** **Correlations between the methylation model and clinical characteristics.** (**A**) The prognostic model. (**B**) Nomogram for predicting the probability of 1-, 3-, and 5-year overall survival of patients with LUAD. (**C**) The recurrent model. (**D**) Nomogram for predicting the probability of 1-, 3-, and 5-year disease-free survival of patients with LUAD. LUAD, lung adenocarcinoma.